Skip to main content
. 2021 Feb 18;9(2):207. doi: 10.3390/biomedicines9020207

Figure 1.

Figure 1

The oncoprint showing the genetic alterations and mRNA expression level of BECN1, BRCA1 and TP53 in 316 ovarian serous cystadenocarcinomas from the TCGA dataset (Consortium TCGA, Nature 2011).